Don’t Miss Out on Rampant Biotech Mergers with the SBIO ETF
January 13, 2021 at 10:47 AM EST
Large cap biotechnology companies are flush with cash, and they’re on the prowl for takeover targets, a scenario that could bode well for the ALPS Medical Breakthroughs ETF (SBIO). SBIO focuses on small- and mid-cap companies that have one or more drugs in either Phase II or Phase III trials....